Psychedelics 2

Psychedelics, including ketamine, have gained renewed attention both for their non-medical use in club settings and their therapeutic potential in treating mental health conditions such as addiction. This session explores various aspects of psychedelic use, from the recreational to the clinical. Topics include the rise in ketamine use globally, especially in Europe, its growing availability, and associated health risks. Additionally, the session examines the self-therapeutic use of psychedelics like psilocybin, MDMA, and ketamine among young people, and the media’s influence on these trends.